Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho GTPase activating protein 11B (ARHGAP11B) is a human-specific protein-coding gene created by partial duplication of ARHGAP11A. It encodes an inactive (lacking GAP enzymatic activity) truncated version of the RhoGAP domain protein. ARHGAP11B plays a key role in amplifying basal progenitors—neural stem-like cells—thereby contributing to neocortex folding and expansion, a hallmark of human brain evolution[1][2][3][4][5]. Mechanistically, ARHGAP11B localizes to mitochondria, where it facilitates glutaminolysis (the metabolism of glutamine to alpha-ketoglutarate via glutamate), influencing energy metabolism and promoting the proliferation of neural progenitor cells[1][4][5]. It does not display canonical RhoGAP activity but has a unique human-specific C-terminal sequence essential for its function in cortical development[1][2][3]. ARHGAP11B is not a recognized therapeutic target, nor are there any known drugs or biomarkers currently in clinical use related to it. However, it is highly significant in evolutionary biology for its role in the increase in neocortex size seen in humans compared to other species[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho GTPase activating protein 11B (ARHGAP11B).